Maintenance phase (week 13+): Target maintenance doses in the trials were 4 mg, 8 mg, and 12 mg once weekly
degraded material is a common source of inconsistent research results
Suddenly eliminating caffeine can trigger withdrawal symptoms including headaches, fatigue, and irritability, which may be mistakenly attributed to Mounjaro
While tirzepatide is excellent for weight reduction, it doesnt sculpt the body
Exenatide ER Trade Names: Byetta (daily) Bydureon (weekly - extended release) Generic (Nov 2024) Drug Class: DPP-IV resistant Incretin (GLP-1 like) Mimetic Mechanism of Action: a synthetic analog of glucagon-like-polypeptide 1 (GLP-1) that is resistant to breakdown by DPP-IV
Patients who experienced good results on GLP-1 agonists like Ozempic but want enhanced efficacy may find Mounjaros dual mechanism delivers the improvement they seek